Open access
Jul 2026
VASN Enhances IGF2BP3 Stability via USP10 Deubiquitination to Promote Triple-negative Breast Cancer Paclitaxel Resistance
A new CEBPB-VASN/IGF2BP3/USP10-ABCB1 axis responsible for paclitaxel resistance in TNBC is uncovered, offering a rationale for precision medicine in resistant TNBC.
Hao-Qi Liu, Zexiu Lu, Mao-Shan Chen et al.
· International Journal on Bio... · 0 citations